Fastest News Updates around the World

Revolutionary Cancer Cure: Implantable Device Developed by Scientists to Treat Cancer in 60 Days


- Advertisement -

Scientists Developing Implantable Device to Cure Cancer in 60 Days

A team of scientists is working on a revolutionary device that can be implanted into the body to cure various types of cancer within just 60 days. Led by Rice University in Houston, Texas, this seven-state team has developed a 76mm diameter implantable device that serves as both a cancer detection system and a drug delivery system.

How HAMMR Works

The device, called Hybrid Advanced Molecular Manufacturing Regulator (HAMMR), is equipped with sensors that monitor rapidly mutating cancer cells. Based on the patient’s response, it adjusts the release of immunotherapy drugs. This feedback therapy approach, which has already been successful in treating diabetes, is considered revolutionary for cancer immunotherapy.

Potential Benefits of HAMMR

- Advertisement -

HAMMR has the potential to significantly improve immunotherapy outcomes for hard-to-treat cancers like ovarian and pancreatic cancer. Scientists believe it could reduce cancer deaths by 50% in the United States. Dr. Amir Al-Jazairi, one of the lead researchers on the team, emphasizes that the device will help gain a deeper understanding of how cancer cells change, enabling parallel changes in treatment approaches.

Implantation and Real-Time Monitoring

A simple procedure allows the device to be implanted into the abdominal cavity, where it continuously monitors the patient’s cancer and adjusts immunotherapy drug doses in real time. The device can communicate wirelessly, possibly with a smartphone, and can be charged externally. This real-time monitoring and adjustment process allows doctors to respond quickly to any changes in the cancer, eliminating the need for lengthy test result waiting periods and the development of new treatment plans.

Future Prospects

The team recently secured funding to conduct a phase I clinical trial for the treatment of recurrent ovarian cancer. While the need for HAMMR is limited to approximately two months, as the team hopes it can cure the patient’s cancer within 60 days, they plan to test the device in humans within the next five years.

Source: Daily Mail

Leave a Reply

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More